Integrative Medicine for Ovarian Cancer

Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20.

Abstract

Purpose of review: Integrative oncology (IO) services provide a wide range of complementary medicine therapies, many of which can augment the beneficial effects of conventional supportive and palliative care for patients with ovarian cancer. This study aims to assess the current state of integrative oncology research in ovarian cancer care.

Recent findings: We review the clinical research both supporting the effectiveness of leading IO modalities in ovarian cancer care as well as addressing potential safety-related concerns. There is growing amount of clinical research supporting the use of IO and implementation of integrative gynecological oncology models of care within the conventional supportive cancer care setting. Additional research is still needed in order to create clinical guidelines for IO interventions for the treatment of female patients with ovarian cancer. These guidelines need to address both effectiveness and safety-related issues, providing oncology healthcare professionals with indications for which these patients can be referred to the IO treatment program.

Keywords: Chemotherapy; Gynecologic oncology; Integrative oncology; Ovarian cancer.

Publication types

  • Review

MeSH terms

  • Complementary Therapies*
  • Female
  • Humans
  • Integrative Medicine*
  • Integrative Oncology*
  • Medical Oncology
  • Neoplasms* / therapy
  • Ovarian Neoplasms* / therapy